RT Journal Article
SR Electronic
T1 Efficacy and safety of lifileucel, a one-time autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma after progression on immune checkpoint inhibitors and targeted therapies: pooled analysis of consecutive cohorts of the C-144-01 study
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e005755
DO 10.1136/jitc-2022-005755
VO 10
IS 12
A1 Chesney, Jason
A1 Lewis, Karl D
A1 Kluger, Harriet
A1 Hamid, Omid
A1 Whitman, Eric
A1 Thomas, Sajeve
A1 Wermke, Martin
A1 Cusnir, Mike
A1 Domingo-Musibay, Evidio
A1 Phan, Giao Q
A1 Kirkwood, John M
A1 Hassel, Jessica C
A1 Orloff, Marlana
A1 Larkin, James
A1 Weber, Jeffrey
A1 Furness, Andrew J S
A1 Khushalani, Nikhil I
A1 Medina, Theresa
A1 Egger, Michael E
A1 Graf Finckenstein, Friedrich
A1 Jagasia, Madan
A1 Hari, Parameswaran
A1 Sulur, Giri
A1 Shi, Wen
A1 Wu, Xiao
A1 Sarnaik, Amod
YR 2022
UL http://jitc.bmj.com/content/10/12/e005755.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.